Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response

NCT02866682 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02866682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2018
Completion date
June 11, 2021
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant rejection